Drug Profile
Research programme: small molecule therapeutics - Amgen/Locus
Latest Information Update: 10 Sep 2008
Price :
$50
*
At a glance
- Originator Amgen; Locus Pharmaceuticals
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 13 Jun 2006 Preclinical trials in Undefined in USA (unspecified route)